Metabolic syndrome and recovery after colorectal cancer surgery
Part of Cancer, Digestive system, Heart & circulation, Hormones & metabolism clinical trials.
This trial studies how metabolic syndrome (a mix of high blood pressure, diabetes, and other factors) changes after colorectal cancer surgery. It aims to understand why some people's metabolic syndrome gets better after their tumor is removed, which could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have had high blood pressure or diabetes for more than 1 year before surgery
- You are scheduled for surgery to remove colorectal cancer (not for emergencies or if cancer has spread to other organs)
- You are not taking certain medications that strongly affect your metabolism (like hormone therapy or strong immune-suppressing drugs)
- Your surgery is not combined with removal of other major organs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how your immune cells change before and after surgery for colorectal cancer, and whether those changes affect your long-term recovery. It may help doctors predict outcomes and improve care.
This study looks at metabolic biomarkers in blood and tumor tissue to help detect colorectal cancer earlier, predict outcomes, and monitor for recurrence. It includes both people newly diagnosed with colorectal cancer and healthy volunteers for comparison.
This study looks at tissue from colorectal cancer surgery to understand how cancer cells use energy, which may help find better treatments. It is open to adults having surgery for colorectal cancer or liver metastases from colorectal cancer.
This study tests if a simple blood test can detect early signs of colorectal cancer coming back after surgery to remove cancer spread in the abdomen. It may help patients avoid unnecessary treatments and catch recurrence sooner.
This trial looks at a health behavior program for people who have had surgery for colorectal cancer. It aims to help you make healthier lifestyle choices to support your recovery and well-being.
This study looks for blood/tumor signals (“biomarkers”) that may help predict outcomes in people whose colorectal cancer returns and spreads after surgery. It mainly helps researchers understand who may do better or worse, which can guide future care.
Hear when a new Metabolomics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.